Blindness
0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
WicabBrainPort Vision Pro
WicabBrainPort V200 Device
WicabBrainPort Vision Device
Clinical Trials (3)
Total enrollment: 220 patients across 3 trials
Evaluation of the Efficacy of the BrainPort Vision Pro on the Performance of Daily Activities in the Profoundly Blind French Population
Start: Oct 2020Est. completion: Sep 2022125 patients
N/AUnknown
A Study to Evaluate the BrainPort Vision Device in Individuals Blinded by Traumatic Injury
Start: Sep 2014Est. completion: Sep 201620 patients
N/AUnknown
A Study to Evaluate the BrainPort® Vision Device in Subjects Who Are Blind
Start: Oct 2011Est. completion: Apr 201375 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space